Market Research Blog – Page 3815 – New Product Development

Global Mixed Xylene Market Set for Remarkable Growth Trajectory: Projected to Reach US$ 94,332.7 million by 2033, Finds Future Market Insights Report

Consumption of mixed xylene is primarily being driven by the expanding usage of this solvent in a variety of end-use industries. Increased investments in bio-based mixed xylene research and development are anticipated to support market growth. For greater performance, blended xylene is utilized to raise the fuel’s overall efficiency and octane value. As consumer concern for the environment rises, it is anticipated that the mixed xylene market in this country will be driven by rising spending on research and development of bio-based fuels. Market expansion is expected to be fueled by rising demand for mixed xylene used as a gasoline blending additive.

The mixed xylene market is projected to achieve a valuation of US$ 52,674.9 million in 2023, with expectations of reaching US$ 94,332.7 million by 2033, reflecting a steady compound annual growth rate (CAGR) of 5.1% over the decade. This growth trajectory underscores the increasing demand for mixed xylene and its significant role in various industries, including chemicals, plastics, and manufacturing, as it continues to be a vital component in the global market.

Get an overview of market drivers and challenges affecting this industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-4965

The market’s growth prospects are amplified by the expanding range of applications for solvents in end-use industries. The potential for market expansion is greatly influenced by the growing demand for PET manufacture. Mixed xylene is in higher demand as a result of the rising demand for RTD beverages. The primary raw material utilized in the production of terephthalic acid, which is used to create the PET monomer bis (2-hydroxyethyl) terephthalate, is mixed xylene. As a result, there is a connection between the demand for PET bottles and mixed xylene.

Across Asia Pacific, China is the world’s largest consumer of mixed xylene. Consumption of mixed xylene is anticipated to be significantly influenced by the growing use of this solvent in a variety of end-use sectors. Over the course of the projection period, increased manufacturing of polyester products such polyethylene terephthalate (PET), films, and fibres in China is anticipated to have a significant impact on shipments of mixed xylene.

Key Takeaways from the Mixed Xylene Market Report:

The global mixed xylene market expanded at a remarkable CAGR of 6.5% from 2017 to 2022.
In 2017, the global market size stood at US$ 36,011.10 million.
The global mixed xylene market accounted for US$ 49,439.7 million in 2022.
Isomer grade mixed xylene currently accounts for more than 70% of the global mixed xylene market share.
In 2022, the raw material mixed xylene application segment captured a staggering 83.4% market share.
The chemicals segment captured 82.6% of the global mixed xylene market share in 2022.
China mixed xylene market held 6.7% global market shares in 2022.
The United States accounted for 16.3% of the global mixed xylene shipments in 2022.
The market for mixed xylene in the United Kingdom held a 4.3% market share in 2022.

Recent Developments Observed by FMI:

Agilyx and BioBTX collaborated to create circular aromatic compounds in April 2023. A commercial demonstration plant for the production of renewable aromatic compounds (toluene, benzene, and xylene) will benefit from the collaboration by strengthening BioBTX technology.

Key Players in Mixed Xylene Market:

Exxon Mobil Corporation
TOTAL S.A., GS Caltex Corporation
Idemitsu Kosan Co. Ltd.
LOTTE Chemical CORPORATION
Royal Dutch Shell PLC
China National Petroleum Corporation
Chevron Phillips Chemical Company LLC
China Petroleum & Chemical Corporation
Flint Hills Resources LLC
YPF Sociedad Anonima
SK Global Chemical Co. Ltd.

Contact Sales for Further Assistance in Purchasing this Report: https://www.futuremarketinsights.com/checkout/4965

Mixed Xylene Market Segmentation

By Grade:

Isomer Grade Mixed Xylene
Solvent Grade Mixed Xylene

By Application:

Fuel Blending
Solvents
Thinners
Raw Materials

By End-use:

Mixed Xylene for Paints & Coatings
Mixed Xylene for Pesticides
Mixed Xylene for Chemicals
Mixed Xylene for Gasoline
Mixed Xylene for Printing
Rubber & Leather

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Aircraft Cleaning Chemicals Market Set to Reach US$ 3774.17 million by 2032, Fueled by Post-Pandemic Hygiene Awareness and Tourism Boom

According to Future Market Insights estimates, the North American Aircraft Cleaning Chemicals Market is predicted to reach a market valuation of US$ 1,875 Million by the end of 2022. During the forecast period of 2022-2032, the North American market is expected to grow with a steady CAGR of 4% and hence reach a market value worth US$ 3,255.5 Million by 2032.

North America presently has the biggest economy for aircraft cleaning chemicals, according to research by Future Market Insights. Sales of aircraft cleaning chemicals are anticipated to soar during the projection timeframe in North America due to rapid technological advancement in the aviation sector and aggressive government actions to maintain a sanitary environment in the aircraft.

According to data from aviationbenefits.org, the GDP of North America is boosted by air travel by close to US$ 1.1 trillion. In addition, the aviation sector in North America accommodates the greatest number of both local and foreign travelers. Additionally, ammonia-free aviation cleaner spray is readily available and penetrates fast to lift as well as dissolve dirt deposits, smoke films, greasy stains, fingerprints, and other contaminants off the glass surface. Such factors are further expected to propel the growth in the North American region.

However, the market rebound in Asia, China, and the MEA is expected to cause North America to lose a sizable share of the market in aircraft cleaning chemicals by the end of 2029. As Asia has become a major hub for air travel and is predicted to hold its own over the next ten years, the market in North America is expected to lose some significant market share in the coming years.

Get an overview of market drivers and challenges affecting this industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-3155

Key Takeaways

The North American market for aircraft cleaning chemicals was estimated to hold a market valuation of US$ 1,655 Million in 2022.
Globally, the North American market will occupy a 36% share in 2022.
By product type, dry wash cleaning is expected to occupy 38% of the shares in 2022.
By formulation, water-based cleaners are mostly preferred by experts.
By end-use, civil aircraft are expected to acquire 51% of the shares in the North American market.

Competitive Landscape

The key players present in the North American aircraft cleaning chemicals market are

PPG Industries Inc.
Illinois Tool Works Inc.
Callington Haven Pty Ltd.
Mcgean-Rohco Inc.
Arrow Solutions
Nuvite Chemical Compounds
Rx Marine International
Roovel Solutions Pvt. Ltd.
Ecosterile Environmental Technologies Pvt. Ltd
Anu Enterprises
RPM Technology, LLC
Alglas United Kingdom
DASIC International Ltd & DASIC International Aerospace Ltd

The primary companies are concentrating on creating items that support strong health as well as a new aspect of safety, which is creating formulae for non-flammable products. These have a mild odor and are quite inexpensive as a whole. In addition, the recently produced product offers less chemical evaporation, which further boosts the product’s effectiveness.

Recent Developments

In October 2022, Nuvite released SS9-3, a ground-breaking solution that satisfies CSD1, D AMS 1526C, and D6-17487 criteria and is approved for both general and exterior aviation cleaning. This cleanser’s alkaline base makes it an ideal aircraft cleaning solution for all kinds of surfaces- gloss, satin, and matte.
PPG stated in September 2022 that it would exhibit its new color simulation tool and shed paint color pallet at the 2022 Shed Builder Expo. The PPG AQUACRON color palette for the coatings, which was just introduced, is one of the first to be created utilizing customer choice and shed manufacturers’ suggestions.

Interested in Procuring the Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-3155

Aircraft Cleaning Chemicals Market Segment

By Product Type:

Exterior
- Dry & Wet Wipes
- Dry wash Cleaning
- Wet Wash Cleaning
- Degreasers
- Exhaust & Soot removers
- Polishes
Interior
- Equipment Cleaning
- In Flight Wipes
- Glass Cleaners
- Air Fresheners
- Leather Cleaner
- Carpet Cleaner
- lavatory Cleaner
- Disinfectant
- Insecticides

By Formulation:

Water Based
Solvent-based
- Synthetic
- Bio-Based
Wax Based

By End Use:

Civil Aircraft
Commercial/Cargo Based Aviation
Military

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Isoprene Rubber Latex Market Set to Witness Staggering Growth with 8.1% CAGR, Propelled by Expanding Applications in Medical and Consumer Goods Sectors, Finds Latest FMI Study

Isoprene rubber latex is utilized in many industries, including healthcare, automotive, and consumer goods, and it offers long-lasting and durable solutions. Isoprene rubber latex is a versatile polymer that is used in the production of a wide range of rubber products. It possesses high tensile strength, flexibility, and abrasion resistance.

According to a Recent Report by Future Market Insights (FMI), the Global isoprene rubber latex market Is Expected to Achieve an 8.1% CAGR Between 2021 and 2031, Driven by the Increasing Demand for Medical Gloves and Condoms. Isoprene Rubber Latex Market Takes the Lead.”

Expanding Utilization in Medical and Consumer Goods Industries Sets the Stage for Market Growth in the Near Future.

In 2021, the global isoprene rubber latex market is anticipated to be worth US$ 732.5 million. The increasing use of isoprene rubber latex in consumer products, industrial, and medical industries is expected to drive market demand.

Isoprene rubber latex is gaining immense popularity as an alternative to natural rubber. It possesses superior properties such as high resilience, good processability, and easy vulcanization, among others. In response to this, the market is estimated to surpass US$ 1,602.0 million by the end of 2031.

Growing use of isoprene rubber latex in the production of medical supplies such as catheters, probe covers, needle shields, and medical adhesives is expected to drive the sales at 8.1% CAGR over the assessment period.

Governments of several countries are undertaking various initiatives to spread awareness regarding sexually transmitted diseases (STDs) and use of condoms. For instance, the Indian Government announced distributing nearly 180 million pieces of condoms to decline the risk of STD, under the National AIDS Control Programmed in 2019.

Get an overview of market drivers and challenges affecting this industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-7639

As condoms are made using isoprene rubber latex, adoption is expected to surge over the coming years. On account of this, the market is expected to register 10.1% year-on-year (YoY) growth in 2021.

In terms of application, the medical gloves segment is anticipated to outpace the other segments, expanding at 9.2% CAGR in 2021. Rise in demand from doctors, nurses, patients, and other professionals to decline the risk of getting infected during the COVID-19 times have increased the sales of medical gloves.

Key Takeaways:

U.S. isoprene rubber latex market is projected to total US$ 99.4 million, exhibiting a YoY growth of 8.8% by the end of 2021.
China is expected to account for the largest share in the East Asia market, exhibiting growth at a CAGR of 8.8% through 2031.
Germany market is anticipated to account for nearly 14.3% of the share in Europe, expanding at 6% CAGR over the assessment period.
Japan and South Korea are forecast to emerge as highly remunerative markets, collectively accounting for more than 6.1% of sales in 2021.
Based on end use, the industrial sector is estimated to register the fastest growth in the market, expanding at a 7.5% CAGR between 2020 and 2021.

“Rising demand of medical gloves from healthcare industry and the increasing usage of adhesives in food, medical and industrial packaging will drive the market of isoprene rubber latex through the projected period from 2021 to 2031,” says a FMI analyst.

Competitive Landscape

Key market participants in the global isoprene rubber latex market elaborated in the report includes Top Glove Corporation Bhd, Zeon Corporation, PAO Sibur Holdings, Kraton Corporation, Ansell Limited, Supermax Corp. Bhd, Royal Dutch Shell Plc, Kossan Rubber Industries Bhd, JSR Corporation, Hartalega Holdings Berhad, Rubberex Corporation, Johnson Wilshire, Medline Industries, Inc., Dipped Products Plc, Protective Industrial Products, Inc., and many others.

Key players operating in the global isoprene rubber latex market are focusing on increasing their production capacities to strengthen their footprint especially in the emerging economies. Furthermore, key market participants are focusing on mergers, acquisitions and collaborations strategies to expand their global presence and strengthen their distribution network. For instance:

In April 2018, Top Glove Corp Bhd acquired Aspion Sdn Bhd transforming the company into one of the world’s largest surgical glove maker and strengthening its position as the world’s largest glove manufacturer.

Interested in Procuring the Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-7639

Key Drivers

Increasing government regulations to prevent STD and control unbridled population growth in China, India, the U.S., and Indonesia are driving the sales across the condom segment.
Implementation of stringent regulation on increasing patient care across hospitals and clinics is encouraging physicians to use medical gloves, which is in turn, propelling the demand in the medical gloves segment.

Key Restraints

High cost of isoprene rubber latex compared to natural rubber is hindering the sales in the market.
Availability of alternatives such as butyl rubber, nitrile rubber, silicone rubber, and others is hampering the growth in the market.

Key Segmentation

By Application:

Medical Gloves
Condoms
Medical Balloons
Catheters
Adhesives

By End Use:

Medical
Consumer Goods
Industrial

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Decorative Plastic and Paper Laminates Market Set to Surpass US$ 113 Billion by 2028, Unveiling Lucrative Opportunities for Industry Players

Decorative plastic and paper laminates are expected to grow at a 5.5% CAGR over the forecast period. The global Decorative Plastic and Paper Laminates market is expected to generate an additional US$ 46 billion between 2018 and 2028. The global decorative plastic and paper laminates market is anticipated to be worth US$ 66 billion by the end of 2018 and US$ 113 billion by the end of 2028.

Decorative plastic and paper laminates are adaptable materials that can be used to enhance the appearance and durability of a wide range of surfaces. They come in a variety of shapes, textures, and finishes, making them ideal for use in interior design. These laminates, which range from furniture to wall panels, offer a low-cost way to create stylish and visually appealing interiors while protecting underlying surfaces.

Decorative laminates are laminated sheets composed of kraft papers and decorative printed papers that have been fused together using pressure and heat. They are the surface materials that are used to protect and enhance the appearance of engineered wood. Decorative plastic and paper laminates are commonly used in the manufacture of cabinets, countertops, floors, and furniture, among other things.

Get an overview of market drivers and challenges affecting this industry: https://www.futuremarketinsights.com/reports/sample/rep-gb-7610

Key Insights at a Glance

A third of the total market revenue is accounted by China, followed by Eastern Europe. FMI points to remarkable progress in sales of decorative plastic and paper laminates within BRICS countries.
Soaring demand for decorative foils and papers in the commercial sector is prominently responsible for superiority of low pressure laminates over high pressure counterparts.
As smaller players dominate the market, the strategic focus remains on product differentiation and cost competitive pricing. Reduced VOC emissions is another important factor dictating strategic moves of manufacturing SMEs.
Key players in decorative plastic and paper laminates landscape are currently concentrating on channelizing their efforts towards strengthening the distribution network, in addition to establish a direct sales channel.

Rapid Recovery of Residential Housing Sector Firms up the Base for Decorative Plastic & Paper Laminates Demand

Although commercial sector currently dominates in terms of demand for decorative plastic and paper laminates, residential housing sector is likely to take over soon. The residential construction realm has been witnessing strong signs of recovery over the past couple of years, which is playing a key driving force for the revenue growth of decorative plastic and paper laminates landscape.

Moreover, rapid growth of hospitality sector is providing a strong impetus to product innovation, thereby pushing the growth of leading bands dealing in decorative plastic and paper laminates landscape. Commercial construction is also significantly favoring the sales decorative plastic and paper laminates, as indicated by the report.

Manufacturers of decorative plastic and paper laminates are also capitalizing on opportunities presented by a growing number of remodeling and repainting projects.

Wooden Flooring Trends among Consumers, Following Furniture & Cabinets

Furniture and cabinets account for over half the share of total market value, whereas flooring applications are likely to gradually take over,” says the analyst.

Shifting consumer preferences for laminate flooring in both residential and commercial sectors is creating a heap of investment opportunities for manufacturers of decorative plastic and paper laminates.

“Consumers today seek endurance, scratch resistance, and aesthetics while purchasing furniture for homes or workplaces. Such factors are provide the trigger for application specific innovations in decorative plastic and paper laminates,” the analyst explains further.

Spectacular growth prospects are identified for Asia, North America and some parts of Eastern Europe.

Interested in Procuring the Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-7610

Mushrooming Popularity of RTA Furniture Favors Global Sales of Decorative Plastic & Paper Laminates

Constant design innovation, consistent focus on superior quality, and maximum convenience are collectively driving consumer appeal for ready-to-assemble (RTA) furniture, especially in developed markets of North America and Europe.

Manufacturers of both RTA furniture and decorative plastic and paper laminates are taking efforts to collaboratively unlock the opportunities – with an additional benefit of less susceptibility to damage during transit and shipping. Penetration of RTA furniture into developing economies is also gradually increasing owing to relatively lower price point and maintenance cost, thereby contributing to sales of decorative plastic and paper laminates.

Digital Print Designs on Decorative Plastic and Paper Laminates Gather Considerable Momentum

Personalization has been trending across industries, and interior decoration is among the prominent ones. Customized digitally printed laminates are especially designed to cater to specific consumer demands regarding print design, pattern, and graphic.

Sheets of digital decorative plastic and paper laminates have high resolution images printed on them, and can be directly applied on furniture, doors, commercials, exhibition stands, and walls. Digital print laminates are creating a slew of opportunities for manufacturers in the decorative plastic and paper laminates landscape.

Key Segmentation

By Type

Low Pressure
High Pressure
Edge Banding

By Application

Furniture and Cabinets
Flooring
Wall Paneling
Doors
Column Cladding

By End Use

Residential
Commercial
Institutional

By Region

North America
Latin America
Western Europe
Eastern Europe
SEA
India
China
Japan
MEA

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Sodium Bicarbonate Market Set to Reach US$ 7.7 billion by 2033, Fueled by Healthcare Demand Surge and Sustainability Trends

The trend is predicted to open up new potential for the sector, with a 5.2% CAGR between 2023 and 2033 and a total market value of around US$ 7.7 billion by 2033. The global sodium bicarbonate industry is anticipated to reach a valuation of US$ 4.6 billion in 2023, fueled by increased demand from the healthcare business.

Rising demand from the food and beverage industries is one of the key reasons driving the growth of the sodium bicarbonate market. Sodium bicarbonate is a common leavening additive in baked goods, giving bread, cakes, and pastries a distinctive rise and texture. Demand for sodium bicarbonate is rising as a result of the growing baking industry and rising convenience food consumption. The growing trend of clean label products, as well as the demand for natural ingredients in food and beverages, are driving market expansion. Because of its natural origins and minimum processing, sodium bicarbonate fits neatly within the clean label product category.

Growing awareness of sodium bicarbonate’s various properties and eco-friendliness is another major factor driving market expansion. Consumers are becoming more conscious of the environmental effect of the products they use, which is fueling demand for sustainable and environmentally friendly solutions. Sodium bicarbonate, being a natural product, matches to these consumer desires. It is non-toxic, biodegradable, and rich in mineral resources, making it an enticing choice for businesses seeking environmentally friendly solutions.

Get an overview of market drivers and challenges affecting this industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-3819

The sodium bicarbonate market is also being driven by the healthcare industry. In the pharmaceutical industry, sodium bicarbonate is a popular active ingredient in antacids and buffering agents. It aids in the neutralization of stomach acid and the relief of heartburn and indigestion. With the rising prevalence of gastrointestinal disorders and the increased need for over-the-counter antacid medications, the demand for sodium bicarbonate is skyrocketing.

Key Takeaways from the Market Study

The global sodium bicarbonate market was valued at US$ 4.4 billion by 2022-end.
From 2018 to 2022, the market demand expanded at a CAGR of 2.6%.
China is expected to hold a dominant CAGR of 5.1% during the forecast period.
By End-Use, the processed food segment is expected to constitute a CAGR of 5.1% in 2033.
On the basis of Grade Type, the technical segment is expected to dominate the market with a CAGR of 5.0% in 2033.
From 2023 to 2033, the sodium bicarbonate market is expected to flourish at a CAGR of 5.2%.
By 2033, the market value of Sodium Bicarbonate is expected to reach US$ 7.7 billion

“Government regulations and initiatives, across the globe is a major factor that is expected to propel the growth of the sodium bicarbonate market in the near future,” remarks an FMI analyst.

Competitive Landscape

Prominent players in the Sodium Bicarbonate market are

Solvay SA
Merck KGaA
Nirma ltd.
Tata Chemicals Ltd.
GHCL Ltd.
Ciech SA
DCW Ltd.
Seqens Group
Tosoh Corporation
Hawkins, Inc.
Vitro
Church & Dwight Co., Inc.

Recent Developments

In January 2023, Tosoh Corporation announced the completion of a new production facility for high-purity sodium bicarbonate in Japan. The facility is equipped with advanced technology to meet the increasing demand for high-quality sodium bicarbonate in various industries, including pharmaceuticals and healthcare.
In September 2022, Novacap Group announced the acquisition of a sodium bicarbonate production site from Seqens in France. This acquisition expands Novacap’s production capacity and strengthens its position as a leading supplier of sodium bicarbonate in Europe, enabling it to better serve the growing customer base.
In July 2022, Brunner Mond Group announced plans to invest in a new sodium bicarbonate production plant in the United Kingdom. The new plant will utilize advanced technologies to enhance production efficiency and meet the increasing demand for sodium bicarbonate in various industries, such as pharmaceuticals, food, and agriculture.

Interested in Procuring the Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-3819

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global sodium bicarbonate market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the sodium bicarbonate market, the market is segmented on the basis of grade type (pharmaceutical grade, technical grade, food grade, and feed grade), by end-use (processed food, pharmaceuticals, personal care products, chemicals, agrochemicals & nutrients, detergent, fire extinguisher, leather & dyeing, and others), by form (powder, pellets, slurry, and liquid), across five major regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa (MEA)).

Key Segments Profiled in the Global Sodium Bicarbonate Market

By Grade Type:

Pharmaceutical Grade
Technical Grade
Food Grade
Feed Grade

By Form:

Powder
Pellets
Slurry
Liquid

By End Use:

Processed Food
Pharmaceuticals
Personal Care Products
Chemicals
Agrochemicals & Nutrients
Detergent
Fire Extinguisher
Leather & Dyeing
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Infertility Drugs Industry Sets Sights on US$6.8 Billion by 2033, Propelled by a Remarkable 6.3% CAGR | Exclusive Findings by FMI Reports

The Global Infertility Drugs Industry is on the brink of a transformative journey, with the market size reaching a staggering US$ 3,699.8 million in 2023 and anticipated to soar to US$ 6,814.68 million by 2033. According to an in-depth analysis by Future Market Insights Inc., this trajectory reflects a notable Compound Annual Growth Rate (CAGR) of 6.3%.

As infertility concerns continue to rise globally, there has been an unprecedented surge in the demand for cutting-edge infertility drugs. Both men and women are equally affected by infertility, with causes ranging from age-related factors to specific health conditions.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-16593

Key Takeaways from Global Infertility Drugs Industry Study

The infertility drugs market is expected to record a CAGR of 6.3% over the forecast period.
According to estimates, the infertility drugs market in North America may remain strong throughout the length of the forecast period.
The gonadotropins segment dominated the infertility drugs market with a revenue share of 40.1% in 2023 and is expected to grow rapidly.
The women’s segment dominated the market for infertility drugs in 2023 with a revenue share of 71.3%.

Global Infertility Drugs Industry Competitive Landscape:

Several prominent companies dominate this market, including Ferring Pharmaceuticals Inc., Merck KGaA, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Theramex, Novartis AG., Abbott Laboratories, Bayer AG, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Ferring Holdings SA, Organon & Co., Mankind Pharma Ltd., and others.

Sustainable and environmental footprint awareness may drive the choice of active ingredients and materials for the Infertility Drug Market, as well as packaging. By engaging in these activities, manufacturers can expand their product portfolios, expand their geographical reach, and capture a larger share of the market.

In addition to gaining access to the latest markets and advanced technologies, key players can also gain access to new markets by partnering with other companies. In addition, companies can acquire, merge, and diversify their portfolios.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16593

Global Infertility Drugs Industry Segmentation by Category

By Drug Class:

Gonadotrophins
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Biguanides
Other Drug Classes

By End User:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels

By Region Outlook:

North America
Latin America
Europe
The Middle East and Africa
East Asia

Global Infertility Drugs Industry Recent Developments:

Genea Biomedx (Australia) partnered with Hamilton Thorne in 2020 to sell its fertility products in the United States and Canada.
The Pergoveris Pen is the first pen injector for gonadotropins, which are hormones that play a crucial role in reproduction and fertility. It was introduced to India in August 2021 by Merck, to treat infertility.
The Fertility Partners, the leading provider of fertility services in Canada, has partnered with Maven Clinic to form a referral network for fertility clinics. Maven’s network helps its members find high-quality fertility care in over 70 countries. The company also launched MavenRx, its new medication service, in February 2020, to help fertility members get their medications more seamlessly.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/16593

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:

Global Pleural Diseases Therapeutics Industry Set to Flourish with a Projected 6.5% CAGR, Reaching US$ 9.4 Billion by 2033 | FMI

Global Pleural Diseases Therapeutics Market

Future Market Insights (FMI), a leading market intelligence and consulting firm, has released a comprehensive study on the Global Pleural Disease Therapeutics Industry, shedding light on its anticipated growth trajectory from 2023 to 2033. The market is projected to be valued at US$ 4.98 billion in 2023, with a remarkable compounded annual growth rate (CAGR) of 6.5%.

The study indicates that the Global Pleural Diseases Therapeutics Industry is expected to reach an impressive US$ 9.4 billion by the end of the forecast period, driven by several key factors. Delay in the diagnosis of pleural effusion, a critical aspect of pleural diseases, is identified as a potential threat to patient health, emphasizing the urgent need for efficient treatment procedures. The report highlights that this delay could lead to increased mortality and morbidity rates, further accentuating the demand for advanced therapeutics.

One of the major driving forces behind the market growth is the increasing prevalence of pleural effusion among patients with systemic lupus erythematosus and idiopathic and familial pulmonary hypertension. For instance, the study reveals that 30% to 50% of systemic lupus erythematosus patients are more likely to suffer from pleural effusion, while 21.5% of idiopathic and familial pulmonary hypertension patients are estimated to be affected by the condition. This surge in incidences, coupled with proper diagnosis and the availability of expertise offering pleural effusion surgeries, is expected to propel the market growth of pleural disease therapeutics during the forecast period.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-16576

On the other hand, the development activities by the key players in the form of product launches, mergers and acquisitions, and investments are also projected to support market expansion. For example, in September 2021, BDR Pharma developed and launched ‘BIAPENEM’. This is used in the treatment of patients suffering from intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections. This drug is widely distributed and penetrates well into various tissues like- lung tissue) and body fluids like- sputum, pleural effusion, abdominal cavity fluid). These kinds of advancements are anticipated to fuel market growth of Pleural disease therapeutics during the forecast period.

Key Takeaways from the Global Pleural Diseases Therapeutics Industry Study

North America is expected to dominate the industry while reaching market share of around 45% by end of the forecast period
The market in Europe is projected to account for 29% market share during the projected timeline
By treatment type, thoracentesis is projected to account for 34% market share by end of the forecast period
Hospitals are expected to dominate the market by end-user, with a market share of 65 % by 2033
Global market for pleural disease therapeutics to reach US$ 4.98 billion by the end of 2023

“Adoption of novel drugs and mergers and acquisitions between companies are going to positively influence market of Pleural disease therapeutics during the forecast period,” comments an FMI analyst.

Reach Out to Our Analyst For Your Queries

https://www.futuremarketinsights.com/ask-question/rep-gb-16576

Competitive Landscape

The Global Pleural Diseases Therapeutics Industry is moderately competitive and consists of various key market players. These players are creating novel delivery systems for treating Pleural diseases. This is anticipated to fuel the Pleural diseases therapeutics market. The key players in the market are WakeMed Health and Hospitals, Boston Medical, Max Healthcare, Avik Pharma, Pfizer CentreOne, Hovione, Pipelinepharma, Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bausch Health Companies Inc., Sanofi S.A.

Key market players are focusing on the adoption of inorganic growth strategies such as acquisition, partnerships, and collaboration to enhance their product portfolio. This is expected to propel the global Pleural diseases therapeutics market.

In September 2021, Bristol Mayer Squibb announced three-year data from the Checkmate -743 trial. According to the clinical trial data, serious adverse reactions occurred in almost 54% of patients receiving OPDIVO plus YERVOY. The most frequent serious adverse reactions reported in ≥2% of patients were pneumonia, pyrexia, diarrhea, pneumonitis, pleural effusion, dyspnea, acute kidney injury, infusion-related reaction, musculoskeletal pain, and pulmonary embolism.
In January 2020, Argon Medical launched single and triple-loop retrieval kits for its U.S. market to improve the lives of patients. The products have managed to secure approval from the United States Food and Drug Administration, and are efficient in the removal of retrievable IVC filters with the help of a jugular approach. These single and triple-loop retrieval kits are the only 2 kits to have received FDA approval in terms of any retrievable IVC filter from a jugular approach.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/16576

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global pleural disease therapeutics market, providing historical data for 2018-2022 and forecast statistics from 2023-2033.

To understand opportunities in the Global Pleural Diseases Therapeutics Industry is segmented based on treatment (drug class, bullectomy, chemotherapy, video-assisted thorascopic surgery – vats, pleurx catheter, pleurodesis therapy, radiation therapy, thoracentesis, thoracostomy, tumor ablation) and end user (hospitals, specialty clinics, others) across five major regions (North America, Latin America, Europe Asia Pacific and Middle East and Africa).

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

Key Segments Profiled in the Global Pleural Diseases Therapeutics Industry Survey

By Treatment:

Drug Class
- Antibiotics
- Antifungals
- Corticosteroids
- Narcotic Analgesics
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Bullectomy
Chemotherapy
Video-assisted thoracoscopic Surgery (VATS)
PleurX Catheter
Pleurodesis Therapy
Radiation Therapy
Thoracentesis
Thoracostomy

By End Users:

Hospitals
Specialty Clinics
Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Next Generation Immunotherapies Industry Poised for Remarkable 7.5% CAGR Growth, Surpassing US$ 268.84 Billion by 2033 | FMI

The Global Next Generation Immunotherapies Industry is poised for an extraordinary leap, with an estimated valuation exceeding US$ 268.84 billion by the year 2033. According to Future Market Insights (FMI), the market is set to achieve this remarkable growth with a compelling compound annual growth rate (CAGR) of 7.5%, spanning from 2023 to 2033.

Immunotherapies, especially those focusing on enhancing the adaptive response of the immune system, particularly cytotoxic T cells, have been pivotal in the fight against cancer. This strategy is anticipated to be a driving force behind the expansive growth of the Next Generation Immunotherapies Market.

In the wake of the unprecedented global challenges posed by the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, the world witnessed a collective effort to develop treatments and vaccines against the virus. With several vaccines now authorized for emergency use, the demand for next-generation immunotherapies has witnessed an exponential surge in recent years.

Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16557

Besides this, the emergence in the incidence of disease, the existence of many government and non-government corporations that reinforce cancer immunotherapy studies, and the expanding authorization of new compounds are bolstering the regional market expansion. Asia-Pacific is predicted to expand at the highest rate during the projected timeframe. Several of the key factors for significant growth are an increment in the aging population, a growing patient platform of a focused disease, and improved medical facilities.

Key Takeaways from the Global Next Generation Immunotherapies Industry Study

From 2018 to 2022, sales increased significantly at a CAGR of 6.9%.
Monoclonal antibodies ruled the drug class, accumulating 71% market share in 2021
The hospital pharmacy segment led the industry in 2021, with a profitability of 56.71%.
The Global Next Generation Immunotherapies Industry is expected to be worth US$ 112.88 billion by 2023.
The global market for Next Generation Immunotherapies is expected to be worth $268.84 billion by 2033.

“The involvement of various administrations and non-governmental organizations that raise awareness and encourage research is assisting in the market’s expansion. Furthermore, increasing funding for the advancement of novel therapeutics is expected to boost R&D initiatives in order to develop the business for Next Generation Immunotherapies.” says FMI’s analyst

Grab Your Report on Discount Before It’s Gone! https://www.futuremarketinsights.com/request-discount/rep-gb-16557

Global Next Generation Immunotherapies Industry Competition:

In January 2023, Boehringer Ingelheim and 3T Biosciences announced a joint strategic alliance and licensing contract to analyse and advance next-generation cancer therapies to address high unmet needs.
Following a fruitful FDA conference in March 2022, MacroGenics finished the Phase 2/3 qualitative research for MGC018 in patients with metastatic castration-resistant prostate cancer (mCRPC).

Global Next Generation Immunotherapies Industry Key Companies Profiled:

Bristol Myers Squibb
Regeneron Pharmaceuticals
MacroGenics
Boehringer Ingelheim
Mereo BioPharma
Huabo Biopharm
Sigma-Aldrich
Avantor, Inc.
Pall Corporation
AstraZeneca
ImmunAbs
IMBiologics
Novacell Technology Inc.

Ask Us Your Questions About This Report https://www.futuremarketinsights.com/ask-question/rep-gb-16557

Key Segments Profiled in the Global Next Generation Immunotherapies Industry Survey

By Drug Class:

Monoclonal Antibodies
Antibody-drug Conjugates – ADC’s
Ace Inhibitors
Immune Checkpoint Inhibitors

By Route of Administration:

Intravenous
Parenteral
Intratumoral
Subcutaneous
Oral

By Distribution Channel:

Hospital Pharmacies
Clinical Pharmacies
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Mechanical Ventilator Industry on Track for 5.7% CAGR, Eyeing US$10.5 Billion Milestone by 2033 | FMI

The Global Mechanical Ventilator Industry, currently valued at US$ 5.7 Billion (2022 revenues), is on a trajectory for robust growth, with Future Market Insights projecting a steady Compound Annual Growth Rate (CAGR) of 5.7% from 2023 to 2033. According to a recent report, the industry is anticipated to achieve a remarkable valuation of US$ 10.5 Billion by the end of 2033.

A key driving force behind this exponential growth is the escalating prevalence of chronic obstructive pulmonary disease (COPD) and a rising incidence of respiratory crises globally. Technical advancements in respiratory care equipment further contribute to the industry’s positive outlook.

The Global Mechanical Ventilator Industry also experienced a notable boost due to the positive impact of the COVID-19 pandemic. During these challenging times, the American Association for Respiratory Care collaborated with various organizations to provide comprehensive training for respiratory therapists in the efficient operation of ventilators. This collaborative effort not only facilitated enhanced skills but also spurred market participants to increase their production capacity to effectively meet the surge in demand.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-16566

Because of respiratory failure due to the COVID-19 virus, the upper respiratory process requires intensive care and oxygen. The ventilator was used to supplement oxygen for extremely sick patients with the COVID-19 virus often. In late November 2021, synthesis of additional variants of COVID-19, high levels of airborne transmission, and a third upsurge in infections were discovered, leading to the possibility of an unprecedented pandemic on a global scale.

Furthermore, major mechanical ventilator manufacturers and the government had taken action to boost ventilator production to address increased demand throughout the pandemic. As a result, the industry’s expansion has been fueled by the existence of many producers as well as government attempts to enhance market output. The expensive expense of mechanical ventilators, as well as the danger of ventilator-related infections such as nosocomial pneumonia, limit their use.

Global Mechanical Ventilator IndustryCompetitive Landscape

Hamilton Medical, Getinge, Drägerwerk AG & Co., Smiths Medical, GE Healthcare, Ventec Life Systems, and Vyaire Medical Inc. are the prominent providers of Mechanical ventilators.

Exploring the study’s key assumptions. Ask An Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-16566

A few of the recent developments of key Global Mechanical Ventilator Industry providers are as follows:

In January 2023, OES Medical debuted a new mains-powered ICU ventilator at the ABHI UK Pavilion at Arab Health 2023 to help hospitals control oxygen demand.
In May 2022, CorVent Medical gained CE Mark clearance and began selling their RESPOND-19 Ventilator in Europe. This method is meant to allow hospitals to enhance the treatment of critically sick patients with acute respiratory distress syndrome by providing an easy-to-use, flexible augmentation of critical care ventilation capacity (ARDS).
In April 2020, Koninklijke Philips N.V. announced that it will increase its hospital ventilator output to 4,000 units per week. In addition, the business expected to begin production of its Philips Respironics E30 ventilator with a weekly output of 15,000 units.

This strategic decision supplemented the company’s current line of mechanical ventilators and added to its unique product portfolio, providing additional options to build highly effective COVID-19 solutions.

In November 2020, Philips announced the introduction of Ventilator BiPAP A40 Expiratory Flow Limitation (EFL), a noninvasive ventilator for COPD patients.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Global Mechanical ventilator industry, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.

The study reveals essential insights by Product (Critical Care, Neonatal, Transport & Portable, Other Product Types), By Ventilation Mode (Invasive, Non-invasive), by End-user (Hospitals, Home Healthcare, Other End-Users), across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-16566

Market Segments Covered in Global Mechanical Ventilators Industry Analysis

By Product Type:

Critical Care
- Ventilators
- Accessories
Neonatal
- Ventilators
- Accessories
Transport & Portable
- Ventilators
- Accessories
Other Product types

By Ventilation:

Invasive
Non-invasive

By End-User:

Hospitals
Home Healthcare
Others

By Region:

North America
Latin America
Europe
APAC
MEA

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Magnetoencephalography Industry on Track to Achieve US$ 485 Million by 2033, Driven by 5.4% CAGR | FMI

Future Market Insights, a leading market research firm, has unveiled its latest report on the Global Magnetoencephalography Industry, providing key insights into the anticipated growth and advancements in neuroimaging technology. According to the report, global sales of Magnetoencephalography in 2022 are anticipated to reach a substantial US$ 273 million.

The Magnetoencephalography Market is poised for remarkable expansion, with a projected valuation of US$ 485 million by 2033, showcasing a Compound Annual Growth Rate (CAGR) of 5.4% from 2023 to 2033. The driving force behind this growth is the increasing demand for MEG scanners in clinical applications, expected to contribute significantly with a CAGR of 5.9% during the same period.

Magnetoencephalography scanners, known for their effectiveness in diagnosing epilepsy, brain lesions, emotional states, pain recognition, and various complex neurological disorders, have become indispensable tools in the medical field. The unique advantage of MEG lies in its ability to utilize neuromagnetic impulses that do not distort as they pass through the skull and scalp, providing unparalleled accuracy in neuroimaging.

Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16555

The HSE Institute for Cognitive Neuroscience, for example, has developed a new approach for processing MEG data that allows for more exact cortical activation zone identification. In both basic clinical and scientific practice, the approach can aid in the diagnosis of a variety of neurological illnesses and the preparation of patients for brain surgery.

Magnetoencephalography is a medical test that analyses the magnetic fields created by the electrical currents in the human brain without piercing or incision into the body. This non-invasive medical test is critical for mapping brain function and pinpointing the origins of epileptic episodes. It is the most advanced way of analyzing the brain’s active functioning using an electromagnetic recording and evaluation process.

With a CAGR of over 5%, Magnetoencephalography revenue in North America is expected to surge at a significant pace. The presence of a large number of market rivals in the region, as well as the high frequency with which new products are released contribute towards the regional market growth. Furthermore, in the United States, patient outcomes and safety are of paramount importance, wherein various projects have been introduced to improve healthcare quality and results.

Global Magnetoencephalography Industry Competitive Analysis

Compumedics Limited
Croton Healthcare
Ricoh USA, Inc.
CTF MEG INTERNATIONAL SERVICES LP
FieldLine Inc.

A few recent developments in the Global Magnetoencephalography Industry are as follows:

In July 2018, York Instruments Ltd. purchased Elekta’s magnetoencephalography business.
In November 2018, Leti introduced a MEG scanning gadget, also known as a wearable brain scanner or MEG helmet. It is designed for improved epilepsy and brain tumor diagnosis.

Click Here to Request Methodology! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16555

Market Segments Covered in Global Magnetoencephalography Industry Analysis

By Application:

Clinical
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Others
Research

By End-use:

Hospitals
Imaging Centers
Academic and research institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube